Cholinergic function modulators claimed for use in nicotine addiction and other disorders by Pfizer Oct. 18, 2001
Two recent clinical studies do not support the use of dopamine D1/5 antagonists in cocaine abuse July 27, 2001
Xenova receives FDA approval to resume clinical trials with anticocaine addiction vaccine July 10, 2001
RSS